GLP-1 Compounding Controversy: What Med Spa Owners Need to Know
Recent FDA rulings on GLP-1 weight-loss medications have created regulatory uncertainty for med spa owners offering compounded treatments.
Read more →Blog
Treatments, regulation and market movement across medical aesthetics.
Recent FDA rulings on GLP-1 weight-loss medications have created regulatory uncertainty for med spa owners offering compounded treatments.
Read more →Drew Smyth of Aesthetic Brokers shares insights on private equity's growing influence in medical aesthetics and what makes practices attractive to buyers.
Read more →A guide to ten leading cosmetic dermatology treatments for 2025, from laser therapy to injectables.
Read more →Advanced technologies and personalized medicine are transforming non-surgical aesthetic treatments and creating new opportunities for practice differentiation.
Read more →